Anticancer drug development guide : preclinical screening, clinical trials, and approval /
In this thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey, Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, leading cancer researchers from pharmaceutical companies, government laboratories, and academia provid...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2004]
|
| Edition: | 2nd ed. |
| Series: | Cancer drug discovery and development.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- High-volume screening / Michel Pagä
- High-throughput screening in industry / Michael D. Boisclair ... [et al.]
- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd
- Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff
- Murine L1210 and P388 leukemias / William R. Waud
- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.]
- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.]
- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.].
- Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman
- Preclinical models for combination therapy / Beverly A. Teicher
- Models for biomarkers and minimal residual tumor / Beverly A. Teicher
- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm
- Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews
- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy
- Nonclinical testing for oncology biologic products / Carolyn M. Laurenìot, Denis Roy, and Paul A. Andrews.
- Working with the national cancer institute / Paul Thambi and Edward A. Sausville
- Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin
- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer.
- Drug development in Europe: the academic perspective / Chris Twelves ... [et al.]
- The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur
- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel
- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari
- FDA role in cancer drug development and requirements for approval / Susan Flamm Honig.